IDX vs NSB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

52MEDIUM

NSB

NEUROSCIEN FPO [NSB]

49LOW

Score Breakdown

IDX NSB
Technical
40
49
Catalyst
58
53
Sentiment
50
50
Fundamental
100
87
Momentum
43
36
Risk Gate
34
46

Key Metrics

IDX Metric NSB
$776.0MMarket Cap$27.7M
872KAvg Volume (20d)301K
+1.4%Short InterestN/A
$3.07052-Week High$0.260
$1.90552-Week Low$0.055
-0.5%Daily Change-4.2%
$2.070Reference Price$0.068
+2.1%ROE-29.6%
+1.8%Profit MarginN/A

Active Signals

IDX Signals

●Stochastic turning bearish from a high level — caution
●Knocking on the door of resistance — if it punches through, things could get interesting
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)

NSB Signals

●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)
●Very high P/S ratio (87.0x)
●Strong revenue growth (+129%)

Ask Scout AI to compare IDX and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IDX vs NUZ →IDX vs PCK →IDX vs PEB →IDX vs RCE →IDX vs SNT →
IDX Full Analysis → NSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).